Welcome to PATH

Path MembersThe Programs for Assessment of Technology in Health (PATH) Research Institute consists of multiple research programs in economic evaluation and health technology assessment (HTA).  PATH's educational and research activities are separated into 5 primary programs:  the Field Evaluation and Economic Assessment Program (FEEAP); the Health Technology Assessment Program (HTAP); the Trial and Economic Modelling Methodology Program (TEMMP); the St. Joseph's Healthcare Hamilton (SJHH) Health Technology Assessment Appraisal & Review Program (SHARP); and the Health Technology Assessment Educational Learning Program (HELP). The PATH Research Institute is affiliated with the Centre for Evaluation of Medicines (CEM) at SJHH and the Department of Clinical Epidemiology and Biostatistics at McMaster University.

Recent News

Recent Reports

  • Assasi N, Blackhouse G.  Newborn screening for Krabbe Leukodystrophy:  a review of the clinical and cost effectiveness and guidelines [Rapid response report: summary with critical appraisal].  Ottawa: Canadian Agency for Drugs and Technologies in Health; 2012. pdf
  • Chandra K, Blackhouse G, McCurdy B, Bornstein M, Campbell K, Costa V, Franek J, Kaulback K, Levin L, Sehatzadeh S, Thabane M, Sikich N, Goeree R. Cost-effectiveness of interventions for chronic obstructive pulmonary disease using an Ontario policy model. Ontario Health Technology Assessment Series; Vol 12:No 12, pp.1-61, March 2012. pdf
  • Bowen JM, Snead OC, Hopkins RB, Elliott I, Burke N, Atkin J, Hebbard M, Brown L, Xie F, Tarride J-E, O’Reilly DJ, Goeree R. Diagnostic evaluation of infants, children and adolescents with epilepsy for surgery candidacy and the role of magnetoencephalography (MEG) [Report No. FEEAP-HTA013a-2011.REP]. Hamilton (ON): Programs for Assessment of Technology in Health, St. Joseph’s Healthcare Hamilton/McMaster University; 2011 pdf

Recent Presentations

  • Zareba P, Tarride J-E.  Changes in Erectile Function after Photoselective Vaporization of the Prostate for Benigh Prostatic Hyperplasia.  Poster presentation at the 2012 Annual Meeting of the American Urological Association (AUA), Atlanta, GA, May 19-23, 2012.
  • Diaby V.  Using Multi-Criteria Decision Analysis to Inform Healthcare Decision-Making in Canada:  A Post-Doctoral Fellow's Perspective. Invited presentation to the Pfizer Research Exchange Dinner, Westin Hotel, Ottawa, ON, April 16, 2012.
  • Ivanova L, O'Reilly D.  Vaccination for Prevention of Herpes Zoster and Postherpetic Neuralgia in Adults over Age 60.  Poster presentation at the CE&B 9th Annual Research Day, McMaster University, Hamilton, ON, March 30, 2012.

Recent Publications

  • Tarride JE, Guo N, Hopkins R, Leslie WD, Morin S, Adachi JD, Papaioannou A, Bessette L, Brown JP, Goeree R. The burden of illness of osteoporosis in Canadian men. Journal of Bone and Mineral Research 2012 [e-pub ahead of print].
  • Dolovich L, Thabane L, Levine M, Holbrook A, Raina P, Goeree R, Nair K, Riemersma K, Kehoe J. The drug safety and effectiveness cross-disciplinary training (DSECT) program. (Editorial) Journal of Population Therapeutics and Clinical Pharmacology  2012;19(1):66-72.
  • Tarride JE, Haq M, O'Reilly DJ, Bowen JM, Xie F, Dolovich L, Goeree R. The excess burden of osteo-arthritis in the province of Ontario, Canada. Arthritis & Rheumatisim 2012;64(4):1153-61.
  • Zhang XH, Li SC, Xie F. Lo NN, Yang KY, Yeo SJ, Fong KY, Thumboo J.  An  exploratory study of response shift in health-related quality of life and utility assessment among patients with osteoarthritis undergoing total knee replacement surgery in a tertiary hospital in Singapore.  Value in Health 2012;15(1 Suppl):S72-8.